|
A sentinel
node biopsy, in which doctors remove only one to three of the
underarm lymph nodes for review by a pathologist, appears to be
a safe and accurate method of screening for the spread of breast
cancer, according to Italian researchers.
The procedure,
which is performed in place of removal of all of the lymph nodes
in the armpit adjacent to the cancerous breast, is viewed by some
doctors as a better option that can help avoid the swelling, disfigurement
and discomfort that sometimes follows the more aggressive surgery.
The theory
is that if the sentinel nodes -- identified by a dye or radioactive
tracer as the nodes receiving fluid from the tumor -- do not contain
cancer cells, then it is likely that the other lymph nodes are
cancer-free as well.
In a report
on their study of 516 women, researchers at the European Oncology
Institute in Milan, Italy, concluded sentinel-node biopsy only
missed stray cancer cells about 9 percent of the time.
"There
was less pain and better arm mobility in the patients who underwent
sentinel-node biopsy only than in those who also underwent [full
lymph node] dissection," the researchers reported.
But in an
editorial in the New England Journal of Medicine where the report
appeared, David Krag and Takamaru Ashikaga of the University of
Vermont College of Medicine contended the Milan study was too
small to resolve the controversy over whether sentinel node biopsies
miss too many cancers.
"The
conclusion that sentinel-node surgery does not result in reduced
survival and therefore that it is a safe procedure ... must await
the completion of larger clinical trials," they wrote.
Other
Sources: New England Journal of Medicine
|